| Previous Close | 0.097 |
| Open | 0.095 |
| Bid | 0.000 x 0 |
| Ask | 0.000 x 0 |
| Day's Range | 0.092 - 0.098 |
| 52 Week Range | 0.082 - 0.390 |
| Volume | 189,318 |
| Avg. Volume | 361,968 |
| Market Cap | 13.92M |
| Beta | 3.83 |
| PE Ratio (TTM) | -1.07 |
| EPS (TTM) | -0.09 |
| Earnings Date | Nov 8, 2017 - Nov 13, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.34 |
- Business Wire•5 days ago
Innovus Pharma’s Partner Luminarie Receives Approval for Zestra® for Female Sexual Arousal Disorder as a Medical Device I from New Zealand’s Medicines and Medical Devices Safety Authority
Innovus Pharmaceuticals, Inc. , an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases, announced today that its partner Luminarie Pty Ltd received approval to commercialize ...
- Business Wire•6 days ago
Innovus Pharma Announces the Launch of Zestra® in France, Belgium and Monaco by Its Partner, Densmore
Innovus Pharmaceuticals, Inc. , an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases, announced today that its distribution partner, Densmore Pharmaceutical International ...
- Business Wire•19 days ago
Innovus Pharma Receives Approval from Health Canada for its UriVarx™ Product for the Indication to Reduce Symptoms of Overactive Bladder such as Daytime Urinary Frequency, Urgency and Nocturia
Innovus Pharmaceuticals, Inc. , an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced that it has received approval from Health Canada to add its clinically proven UriVarx™ product as a Natural Health Product with the indication ...
